Stay updated with breaking news from Small Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initial data from the ongoing Phase 2 trial showed a 12-month overall survival rate of 69% and a median overall survival of 17.5 months in patients with previously treated PD-L1-positive metastatic non-small
Investegate announcements from HUTCHMED Presentations at 2024 ASCO Annual Meeting
CHICAGO, May 23, 2024 /PRNewswire/ -- The Digital Signal Processor market is projected to grow from USD 10.1 billion in 2024 and is estimated to reach USD 14.7 billion by 2029; it is expected
Stock Code: 3380 Alpha Networks Inc. 2023 ANNUAL REPORT Taiwan Stock Exchange Market Observation...